Two SMEs Launch IPOs Today: Injecto Polymers and Century Business Media Capture Investor Attention!

Today marks the commencement of two notable IPOs in the Indian SME sector: Injecto Polymers and Century Business Media, both open for subscription from September 11 to September 16, 2026. Injecto Polymers aims to raise ₹56.12 crore through a book-built issue, offering shares within a price band of ₹98 to ₹100, whereas Century Business Media targets ₹17.11 crore at a price range of ₹70 to ₹74 per share. The shares will be allotted on September 17, with debut listings on the BSE SME platform expected on September 21.

In terms of grey market sentiment, it is important to note that neither IPO has a current grey market premium (GMP), indicating a lack of unofficial enthusiasm among investors. The absence of a GMP suggests a neutral outlook from the market at this stage, which is a critical factor for retail and institutional investors when considering participation in these offers. This could imply a wait-and-see approach from potential subscribers, particularly due to the varying strategies and fundamentals of the two companies.

The implications for Indian investors navigating these IPOs are significant. While both Injecto Polymers and Century Business Media present unique growth stories—one focusing on manufacturing expansion and debt repayment, and the other on enhancing media assets—investors should remain cautious. The absence of any grey market signals indicates that investor enthusiasm may be tempered, warranting a close examination of subscription numbers, business performance, and potential listing responses upon completion of the offer period.

💡
• WEALTHOVA INSIGHTS

Investors should approach the Injecto Polymers and Century Business Media IPOs with a thorough analysis of their business models and growth projections. The lack of a grey market premium indicates cautious sentiment, making careful evaluation essential for any potential investment impacts on portfolios.

Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.


Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)